Cargando…
Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes
BACKGROUND: An increasing body of evidence implicates the resident gut microbiota as playing a critical role in type 2 diabetes (T2D) pathogenesis. We previously reported significant improvement in postprandial glucose control in human participants with T2D following 12-week administration of a 5-st...
Autores principales: | McMurdie, Paul J., Stoeva, Magdalena K., Justice, Nicholas, Nemchek, Madeleine, Sieber, Christian M. K., Tyagi, Surabhi, Gines, Jessica, Skennerton, Connor T., Souza, Michael, Kolterman, Orville, Eid, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742391/ https://www.ncbi.nlm.nih.gov/pubmed/34996347 http://dx.doi.org/10.1186/s12866-021-02415-8 |
Ejemplares similares
-
Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease
por: Stoeva, Magdalena K., et al.
Publicado: (2021) -
Improvements to postprandial glucose control in subjects with type 2 diabetes: a multicenter, double blind, randomized placebo-controlled trial of a novel probiotic formulation
por: Perraudeau, Fanny, et al.
Publicado: (2020) -
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
por: McMurdie, Paul J., et al.
Publicado: (2013) -
Shiny-phyloseq: Web application for interactive microbiome analysis with provenance tracking
por: McMurdie, Paul J., et al.
Publicado: (2015) -
Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible
por: McMurdie, Paul J., et al.
Publicado: (2014)